Forward Pharma A/S American Depositary Shares
FWP was delisted on the 27th of December, 2022.
12 hedge funds and large institutions have $10.1M invested in Forward Pharma A/S American Depositary Shares in 2019 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 2 closing their positions.
100% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 2
100% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 2
20% more funds holding
Funds holding: 10 → 12 (+2)
12% less capital invested
Capital invested by funds: $11.5M → $10.1M (-$1.39M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NM
Newtyn Management
New York
|
+$66.9K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$21.6K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$18.2K |
| 4 |
Morgan Stanley
New York
|
+$9.07K |
| 5 |
AG
Advisor Group
Phoenix,
Arizona
|
+$329 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$16K |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$1K |
| 3 |
PCG
Private Capital Group
West Hartford,
Connecticut
|
-$665 |
| 4 |
FGAM
Financial Gravity Asset Management
Lakeway,
Texas
|
-$22 |
FWP Hedge Fund Activity: Q2 2019 in Review
12 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Forward Pharma A/S American Depositary Shares (FWP) for Q2 2019, worth a combined $10.1M — down 12% from $11.5M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new FWP positions and 2 closed out — a net gain of 2 holders — while 4 added to existing stakes and 2 trimmed.
The largest buyer was Newtyn Management, adding an estimated $66.9K. The largest seller was Renaissance Technologies, exiting entirely with an estimated $16K sold.
- 12 institutional investors held Forward Pharma A/S American Depositary Shares (FWP) as of Q2 2019, up from 10 in Q1 2019.
- Funds reported $10.1M of Forward Pharma A/S American Depositary Shares stock for Q2 2019, down 12% quarter-over-quarter.
- 4 funds opened new Forward Pharma A/S American Depositary Shares positions in Q2 2019 and 2 closed out, a net change of +2 holders.
- The largest Forward Pharma A/S American Depositary Shares buyer in Q2 2019 was Newtyn Management, an estimated $66.9K added.
- The largest Forward Pharma A/S American Depositary Shares seller in Q2 2019 was Renaissance Technologies, an estimated $16K sold.
Based on aggregated 13F filings for Q2 2019.